Medfinder
Back to blog

Updated: January 15, 2026

Why Is Compazine (Prochlorperazine) So Hard to Find? [Explained for 2026]

Author

Peter Daggett

Peter Daggett

Empty pharmacy shelf with medication bottles and magnifying glass

Compazine (prochlorperazine) is in short supply in 2026. Here's why the shortage is happening and what you can do to fill your prescription.

If you've walked into your pharmacy recently and been told that Compazine — or its generic, prochlorperazine — is out of stock, you're not alone. Across the United States, thousands of patients who rely on this medication for severe nausea, vomiting, migraine relief, and other conditions are struggling to get their prescriptions filled. The frustration is real, and the shortage is not your pharmacy's fault.

In this article, we explain exactly why Compazine is so hard to find in 2026, what's driving the shortage, and — most importantly — what steps you can take right now to get your medication.

What Is Compazine (Prochlorperazine)?

Compazine is the brand name for prochlorperazine, a phenothiazine medication that has been used since the late 1950s. It works by blocking dopamine receptors in the brain, which reduces nausea signals and — at higher doses — treats psychiatric symptoms like schizophrenia.

The original Compazine brand has been discontinued. Today, the drug is sold exclusively as generic prochlorperazine in three forms:

Tablets — 5 mg and 10 mg, taken orally 3–4 times daily

Suppositories — 25 mg rectal suppository (Compro brand), useful when nausea prevents oral intake

Injectable solution — 5 mg/mL, typically administered in hospitals and clinics

Why Is Compazine So Hard to Find in 2026?

The shortage affecting Compazine (prochlorperazine) in 2026 is not the result of one single problem. It is the product of several overlapping factors that have been building for years in the generic drug supply chain.

1. Very Few Manufacturers Make It

Prochlorperazine is an old, off-patent generic drug. Because there is little financial incentive to produce it, only a small number of manufacturers make it. When even one of those manufacturers experiences a production problem — a quality issue, an FDA inspection finding, or a facility shutdown — the entire national supply is affected. There is no backup to absorb the gap.

2. Low Profit Margins Remove Any Incentive to Ramp Up

Generic prochlorperazine tablets sell for as little as $0.30 to $1.00 per unit at wholesale prices. This razor-thin margin means manufacturers have almost no financial motivation to increase production capacity, invest in new equipment, or accelerate batch releases when supply runs short. The economics of generic drug manufacturing structurally undermine availability.

3. Sterile Manufacturing Constraints (Especially for Injectables)

The injectable form of prochlorperazine (prochlorperazine edisylate 5 mg/mL) has been listed on the ASHP Drug Shortage Database with recurring availability gaps dating back to 2015. Injectable drugs require specialized sterile manufacturing facilities that are expensive to build and maintain. FDA compliance inspections and facility remediation efforts have repeatedly constrained production across the entire sterile injectables sector — not just for Compazine.

4. International Supply Chain Fragility

Like most generic drugs, prochlorperazine relies on active pharmaceutical ingredients (API) sourced from overseas suppliers — predominantly in India and China. Any disruption in international shipping, regulatory action against a foreign supplier, or geopolitical event can interrupt the flow of raw materials to U.S. manufacturing plants, triggering or worsening a domestic shortage.

5. Pharmacy Chain Distribution Gaps

Large chain pharmacies like CVS, Walgreens, and Rite Aid typically rely on centralized distribution warehouses. When their central supplier is out of stock, every location in the chain is affected simultaneously. This creates an uneven patchwork where one neighborhood has no Compazine and the next town over has shelves full of it. Independent pharmacies often do better during shortages because they source directly from multiple wholesalers.

Which Compazine Formulations Are Most Affected?

As of 2026, the shortage has touched all three formulations at various times:

Injectable (5 mg/mL): Most consistently affected. The ASHP has listed recurring shortages since 2015.

Oral tablets (5 mg, 10 mg): Intermittent shortages at pharmacy level, though more commonly available than the injectable.

Suppositories (25 mg): Also intermittently affected. If tablets are unavailable, suppositories from a different manufacturer may be obtainable and vice versa.

What Can Patients Do Right Now?

Being proactive is your best defense against the Compazine shortage. Here are six steps to take immediately:

Use medfinder to search pharmacies near you. medfinder.com calls pharmacies to check which ones can fill your prescription, saving you hours of phone calls.

Call independent pharmacies. Independently owned pharmacies and compounding pharmacies often have better access during shortages because they source from multiple wholesalers.

Ask your doctor about formulation switching. If tablets are unavailable, your doctor may be able to prescribe suppositories instead, or vice versa. These are made by different manufacturers and may be in stock.

Discuss alternatives with your doctor. Medications like ondansetron (Zofran) or promethazine (Phenergan) may be viable alternatives. Read our guide: Alternatives to Compazine if You Can't Fill Your Prescription

Refill early. If you know you'll need Compazine regularly, try to refill your prescription a few days before you run out, within your insurance's allowed window. This buffer helps if your first-choice pharmacy is out of stock.

Try mail-order or online pharmacies. Amazon Pharmacy, Honeybee Health, and Cost Plus Drugs sometimes carry stock that your local chain pharmacy does not.

Will the Compazine Shortage Get Better?

Drug shortages of old generics like prochlorperazine are notoriously difficult to resolve quickly. The underlying causes — too few manufacturers, low profit margins, and fragile supply chains — are structural problems without easy fixes. The FDA does work with manufacturers to resolve specific shortages, and new suppliers occasionally enter the market, but these processes take months to years.

In the meantime, patients need practical solutions that work today. That's exactly why medfinder exists — to do the calling, searching, and checking so you don't have to.

Stay Informed

For the latest information on the Compazine shortage, read our updated guide: Compazine Shortage Update: What Patients Need to Know in 2026. Staying informed is your first step to staying ahead of the shortage.

Frequently Asked Questions

Compazine (prochlorperazine) is out of stock in 2026 due to a combination of factors: very few manufacturers produce this old generic, low profit margins remove incentives to ramp up production, and the injectable form requires specialized sterile manufacturing that is frequently disrupted. International supply chain fragility adds further risk.

The injectable form of prochlorperazine has been on the ASHP Drug Shortage Database with recurring gaps since 2015. Oral tablet and suppository availability varies by region and pharmacy. The shortage is not new, but remains a significant problem for patients who depend on this medication.

Start by using medfinder.com to find pharmacies near you with Compazine in stock. Call independent pharmacies in your area, as they often have better access than large chains. Ask your doctor if you can switch formulations (e.g., from tablets to suppositories), which may come from a different manufacturer and be easier to find.

Yes — in fact, generic prochlorperazine is the only version available today. The brand-name Compazine was discontinued years ago. The drug is now sold only under the generic name prochlorperazine, in tablet, suppository, and injectable forms.

The injectable form (prochlorperazine edisylate 5 mg/mL) is the most consistently affected by shortages. Oral tablets and suppositories experience intermittent availability gaps but are generally more accessible than the injectable. Trying a different formulation may resolve a supply problem.

Medfinder Editorial Standards

Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.

Read our editorial standards

Patients searching for Compazine also looked for:

32,900 have already found their meds with Medfinder.

Start your search today.

32K+
5-star ratingTrusted by 32,900 Happy Patients
      What med are you looking for?
⊙  Find Your Meds
99% success rate
Fast turnaround time
Never call another pharmacy

Need this medication?